Feig DI - Search Results

1

The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD.

Sato Y, Feig DI, Stack AG, Kang DH, Lanaspa MA, Ejaz AA, Sánchez-Lozada LG, Kuwabara M, Borghi C, Johnson RJ. Sato Y, et al. Among authors: feig di. Nat Rev Nephrol. 2019 Dec;15(12):767-775. doi: 10.1038/s41581-019-0174-z. Epub 2019 Jul 11. Nat Rev Nephrol. 2019. PMID: 31296965 Review.

2

Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?

Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M. Johnson RJ, et al. Hypertension. 2003 Jun;41(6):1183-90. doi: 10.1161/01.HYP.0000069700.62727.C5. Epub 2003 Apr 21. Hypertension. 2003. PMID: 12707287 Review.

3

Hyperuricemia in childhood primary hypertension.

Feig DI, Johnson RJ. Feig DI, et al. Hypertension. 2003 Sep;42(3):247-52. doi: 10.1161/01.HYP.0000085858.66548.59. Epub 2003 Aug 4. Hypertension. 2003. PMID: 12900431 Free PMC article.

4

Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension.

Feig DI, Nakagawa T, Karumanchi SA, Oliver WJ, Kang DH, Finch J, Johnson RJ. Feig DI, et al. Kidney Int. 2004 Jul;66(1):281-7. doi: 10.1111/j.1523-1755.2004.00729.x. Kidney Int. 2004. PMID: 15200435 Free article. Review.

5

Diuretic-induced hyperuricemia does not decrease cardiovascular risk.

Srinivas TR, Herrera-Acosta J, Feig DI, Kang DH, Segal MS, Johnson RJ. Srinivas TR, et al. Among authors: feig di. J Hypertens. 2004 Jul;22(7):1415-7; author reply 1417-9. J Hypertens. 2004. PMID: 15201561 No abstract available.

6

Resurrection of uric acid as a causal risk factor in essential hypertension.

Johnson RJ, Feig DI, Herrera-Acosta J, Kang DH. Johnson RJ, et al. Among authors: feig di. Hypertension. 2005 Jan;45(1):18-20. doi: 10.1161/01.HYP.0000150785.39055.e8. Epub 2004 Nov 22. Hypertension. 2005. PMID: 15557387 No abstract available.

7

Subtle renal injury is likely a common mechanism for salt-sensitive essential hypertension.

Johnson RJ, Rodriguez-Iturbe B, Nakagawa T, Kang DH, Feig DI, Herrera-Acosta J. Johnson RJ, et al. Among authors: feig di. Hypertension. 2005 Mar;45(3):326-30. doi: 10.1161/01.HYP.0000154784.14018.5f. Epub 2005 Jan 17. Hypertension. 2005. PMID: 15655117 Review. No abstract available.

8

Uric acid and hypertension in adolescents.

Feig DI. Feig DI. Semin Nephrol. 2005 Jan;25(1):32-8. doi: 10.1016/j.semnephrol.2004.09.006. Semin Nephrol. 2005. PMID: 15660332 Review.

9

Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed.

Kanellis J, Feig DI, Johnson RJ. Kanellis J, et al. Among authors: feig di. Nephrology (Carlton). 2004 Dec;9(6):394-9. doi: 10.1111/j.1440-1797.2004.00336.x. Nephrology (Carlton). 2004. PMID: 15663643 Review.

10

A unifying pathway for essential hypertension.

Johnson RJ, Rodriguez-Iturbe B, Kang DH, Feig DI, Herrera-Acosta J. Johnson RJ, et al. Among authors: feig di. Am J Hypertens. 2005 Mar;18(3):431-40. doi: 10.1016/j.amjhyper.2004.08.035. Am J Hypertens. 2005. PMID: 15797666 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page